| Literature DB >> 20017839 |
William H Fissell1, Shuvo Roy.
Abstract
The confluence of an increasing prevalence of end-stage renal disease (ESRD), clinical trial data suggestive of benefit from quotidian dialysis, and ongoing cost/benefit reanalysis of healthcare spending have stimulated interest in technological improvements in provision of ESRD care. For the last decade, our group has focused on enabling technologies that would permit a paradigm shift in dialysis care similar to that brought by implantable defibrillators to arrhythmia management. Two significant barriers to wearable or implantable dialysis persist: package size of the dialyzer and water requirements for preparation of dialysate. Decades of independent research into highly efficient membranes and cell-based bioreactors culminated in a team effort to develop an implantable version of the University of Michigan Renal Assist Device. In this review, the rationale for the design of the implantable artificial kidney is described.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20017839 DOI: 10.1111/j.1525-139X.2009.00662.x
Source DB: PubMed Journal: Semin Dial ISSN: 0894-0959 Impact factor: 3.455